Serum Lipoproteins Improve After Successful Pharmacologic Antidepressant Treatment: A Randomized Open-Label Prospective Trial
Abstract
OBJECTIVE: Despite reports of lower plasma cholesterol in depressed patients, major depressive disorder has been shown to increase cardiovascular risk. Our objective was to study the composition of lipoproteins in depressed patients and controls and to examine the effects of pharmacologic treatment and treatment response on lipoprotein composition. METHOD: Lipoprotein composition was analyzed in 65 adult inpatients at a university psychiatric hospital in Germany with DSM-IV major depressive disorder and 33 healthy controls (recruited via newspaper and radio ads) matched for age and sex. After the cross-sectional study phase, the patients were randomized in an open-label prospective trial to treatment with either mirtazapine or venlafaxine. Lipoproteins were reanalyzed after 4 weeks of treatment. Main outcome measures were total cholesterol, the low-density lipoprotein (LDL) to high-density lipoprotein (HDL) cholesterol ratio, and the LDL triglycerides to apolipoprotein B ratio. Secondary outcome measures were total triglycerides, HDL and LDL cholesterol levels, and apolipoproteins A1 and B levels. Comparisons were made between the 2 drug groups and between remitters and nonremitters as measured by the 21-item Hamilton Depression Rating Scale. The study was conducted from April 2003 through December 2007. RESULTS: Total cholesterol at baseline was lower in patients than in controls (mean ± SD = 4.99 ± 0.98 mmol/L vs 5.63 ± 1.01 mmol/L; P = .003), with significantly lower HDL cholesterol (P < .001) and LDL cholesterol (P = .03) in patients. However, the ratio of LDL triglycerides to apolipoprotein B, an index of size and atherogenic potential of LDL particles, was higher in depressed subjects (mean ± SD = 0.46 ± 0.14 mmol/g vs 0.38 ± 0.09 mmol/g; P = .002). Irrespective of treatment allocation, we found significant improvement of cardiovascular risk parameters in remitters but found deterioration in nonresponders. The LDL cholesterol mean change from baseline (remitters vs partial responders vs nonresponders) was -0.06 mmol/L versus +0.39 mmol/L versus +0.56 mmol/L (P = .014); the mean change in LDL/HDL cholesterol ratio was -0.50 versus +0.14 versus +0.80 (P = .002); and the mean change in the LDL triglycerides per apolipoprotein B ratio was -0.01 versus -0.01 versus +0.08 (P = .045). No drug-specific changes in lipid concentrations during treatment were observed except for total cholesterol (venlafaxine group mean = -0.02 mmol/L and mirtazapine group mean = +0.37 mmol/L; P = .033). CONCLUSIONS: In depressed patients, lipoprotein structure is changed toward LDL particles with a higher atherogenic potential. Remission from depression is associated with an improvement of the LDL/HDL cholesterol ratio, shifting lipoproteins toward a less atherogenic composition. Our findings should be confirmed in a larger study, as they have relevance for both researchers and clinicians. TRIAL REGISTRATION: German Clinical Trial Registry Identifier: DRKS00000008.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Improvement of patients' symptoms after antidepressant treatment is accompanied by an improvement in the LDL/HDL ratio.
“In addition, Hummel et al. demonstrated that the improvement of patients’ symptoms after the antidepressant treatment was accompanied by an improvement in the LDL/HDL ratio [154].”
From Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers (2024) · cites this paper as [154]
Cited by
Sorted by citations
Chauvet‐Gélinier, J., & Bonin, B. (2016) · Annals of Physical and Rehabilitation Medicine · doi:10.1016/j.rehab.2016.09.002 · Cited by 262 · see citing works
Ekinci, O., & Ekinci, A. (2017) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2017.1363285 · Cited by 122 · see citing works
“Effective antidepressant treatment modulates some of the dyslipidemic patterns observed in depressive patients, especially TC, HDL and LDL cholesterol [49].”
BackgroundPotential biomarkers in psychiatry: focus on the cholesterol system
Woods, A. G., Sokolowska, I., Taurines, R., Gerlach, M., Dudley, E., Thome, J., & Darie, C. C. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01543.x · Cited by 107 · see citing works
“Low LDL and LDL/HDL and LDL/ApoB ratios are reversed by antidepressant treatment, which is considered to be a favourable change in serum lipoproteins [106].”
BackgroundLongitudinal Relationship of Depressive and Anxiety Symptoms With Dyslipidemia and Abdominal Obesity
Dortland, A. K. B. V. R., Giltay, E. J., van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318274d30f · Cited by 101 · see citing works
Menopause symptom management in women with dyslipidemias: An EMAS clinical guide
Anagnostis, P. G., Bitzer, J., Cano, A., Ceauşu, I., Chedraui, P. A., Durmuşoğlu, F., Erkkola, R., Goulis, D. G., Hirschberg, A. L., Kiesel, L., et al. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.03.007 · Cited by 98 · see citing works
“It is of note that treatment for depression per se, such as with mirtazapine or venlafaxine, may also improve the lipid profile [66].”
BackgroundEndothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Morris, G., Puri, B. K., OLIVE, L. S., Carvalho, A. F., Berk, M., Walder, K. R., Gustad, L. T., & Maes, M. H. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01749-w · Cited by 83 · see citing works
Treatment of Depression in Patients with Concomitant Cardiac Disease
Teply, R. M., Packard, K. A., White, N. D., Hilleman, D. E., & DiNicolantonio, J. J. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.11.003 · Cited by 76 · see citing works
Depression and Cardiovascular Disease: The Viewpoint of Platelets
Amadio, P., Zarà, M., Sandrini, L., Ieraci, A., & Barbieri, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207560 · Cited by 71 · see citing works
Beydoun, M. A., Beydoun, H. A., Dore, G. A., Kuczmarski, M. F., Evans, M. K., & Zonderman, A. B. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.4 · Cited by 45 · see citing works
Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis
Ong, K. L., Morris, M. J., McClelland, R. L., Maniam, J., Allison, M., & Rye, K.-A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.232 · Cited by 41 · see citing works
Curcumin reverses the depressive-like behavior and insulin resistance induced by chronic mild stress
Shen, J.-D., Yu, W., Li, Y., Qiao, J., & Li, Y. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0017-1 · Cited by 43 · see citing works
Bipolar disorder with comorbid binge eating history: A genome-wide association study implicates APOB
Winham, S. J., Barboza, A. B. C., McElroy, S. L., Oliveros, A., Crow, S. J., Colby, C. L., Choi, D., Chauhan, M., Frye, M. A., & Biernacka, J. M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.026 · Cited by 40 · see citing works
Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers
Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works
“In addition, Hummel et al. demonstrated that the improvement of patients’ symptoms after the antidepressant treatment was accompanied by an improvement in the LDL/HDL ratio [154].”
BackgroundLongitudinal Study of Low Serum LDL Cholesterol and Depressive Symptom Onset in Postmenopause
Persons, J. E., Robinson, J. G., Coryell, W. H., Payne, M. E., & Fiedorowicz, J. G. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09505 · Cited by 34 · see citing works
Statins: Neurobiological underpinnings and mechanisms in mood disorders
Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33 · see citing works
Depression trajectories and the association with metabolic adversities among the middle-aged adults
Kim, E. Y., Kim, S. H., Ha, K., Lee, H. J., Yoon, D. H., & Ahn, Y. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.024 · Cited by 34 · see citing works
“This is consistent with earlier research indicating an association among low HDL, hypertriglyceridemia and clinical depression (Hummel et al., 2011; Scharnholz et al., 2014; van Reedt Dortland et al., 2010).”
ResultPositionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie
Ladwig, K., Lederbogen, F., Albus, C., Angermann, C., Borggrefe, M., Fischer, D., Fritzsche, K., Haass, M., Jordan, J., Jünger, J., et al. (2013) · Der Kardiologe · doi:10.1007/s12181-012-0478-8 · Cited by 31 · see citing works
Self-citationHu, Y., Chen, C., Wang, Y., Yang, W., Wang, Y., Zhu, W., Yan, C., & Liu, P. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153467 · Cited by 31 · see citing works
Tang, M., Jiang, P., Huan-de, L., Liu, Y., Cai, H., Dang, R., Zhu, W.-Y., & Cao, L.-J. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0778-1 · Cited by 31 · see citing works
“higher levels of triglyceride (TG), total cholesterol (TCH), low density lipoprotein-cholesterol (LDL-c), free fatty acid (FFA) and lower level of high density lipoproteincholesterol (HDL-c) than normal controls [6–8].”
BackgroundSerum lipid profiles and post-stroke depression in acute ischemic stroke patients
Shen, H., Tu, X., Luan, X., Zeng, Y., He, J., & Tang, W. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s204791 · Cited by 33 · see citing works
Aksay, S. S., Bumb, J. M., Janke, C., Biemann, R., Borucki, K., Lederbogen, F., Deuschle, M., Sartorius, A., & Kranaster, L. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.037 · Cited by 26 · see citing works
“antidepressant treatment (Hummel et al., 2011; Rabe-Jablonska and Poprawska, 2000), thus our results might even underestimate the actual effects of ECT.”
BackgroundMethodResultSelf-citationMolecular serum signature of treatment resistant depression
Ruland, T., Chan, M. K., Stocki, P., Grosse, L., Rothermundt, M., Cooper, J. D., Arolt, V., & Bahn, S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4348-0 · Cited by 26 · see citing works
Peng, Z., Deng, B., Jia, J., Hou, W., Hu, S., Deng, J., Lin, W., Hou, L.-C., & Sang, H. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.014 · Cited by 23 · see citing works
“Coincidentally, all the above mentioned functions of LXRs activation including promoting neurogenesis and synaptic plasticity, preventing neurodegeneration, inhibiting inflammation, as well as regulating cholesterol and glucose metabolism are in line with all proposed mechanisms of action of current antidepressants (D…”
Scharnholz, B., Gilles, M., Marzina, A., Kommer, M., Lederbogen, F., Wudy, S. A., Hartmann, M. F., Westphal, S., Roth, H. J., Kahl, K. G., et al. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.030 · Cited by 21 · see citing works
“, 1994) as well as clinical approaches (Hummel et al., 2011).”
InfluentialSelf-citationOff-Target Effects of Antidepressants on Vascular Function and Structure
Dimoula, A., Fotellis, D., Aivalioti, E., Delialis, D., Polissidis, A., Patras, R., Kokras, N., & Stamatelopoulos, K. S. (2021) · Biomedicines · doi:10.3390/biomedicines10010056 · Cited by 21 · see citing works
“Conversely, in an RCT including 65 patients with depression [87], venlafaxine and mirtazapine improved the LDL/HDL ratio only in responders.”
BackgroundTalking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits
Benedetto, B. D., Rupprecht, R., & Czéh, B. (2013) · Current Drug Targets · doi:10.2174/1389450111314110011 · Cited by 20 · see citing works
“ADs might therefore reverse the dearth of such lipoprotein complexes in the CNS [54], in addition to body fluids, through the enhancement of cholesterol release from glial cells and activation of synaptogenesis in regions affected in MDD [22].”
BackgroundPostpartum Lipid Levels in Women with Major Depression
Prairie, B. A., Wisniewski, S. R., Luther, J. F., Sit, D. K. Y., & Wisner, K. L. (2012) · Journal of Women s Health · doi:10.1089/jwh.2011.3256 · Cited by 19 · see citing works
The lipid paradox in neuroprogressive disorders: Causes and consequences
Morris, G., Berk, M., Walder, K., O’Neil, A., Maes, M., & Puri, B. K. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.017 · Cited by 17 · see citing works
Luppino, F. S., Bouvy, P. F., Giltay, E. J., Penninx, B. W. J. H., & Zitman, F. G. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2014.05.018 · Cited by 17 · see citing works
“Their findings were mostly in line with our results, as TC levels were found to be lower in the inpatient sample versus controls [31,32].”
InfluentialDiabetes to cardiovascular disease: Is depression the potential missing link?
Singh, P., Khullar, S., Singh, M., Kaur, G., & Mastana, S. S. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.01.033 · Cited by 17 · see citing works
“vent them from atherogenic potential of LDL, as they have higher ratios of LDL triglycerides to apolipoprotein B [97].”
BackgroundAssociation between triglyceride and depression: A systematic review and meta-analysis
Xu, D.-R., Gao, X., Zhao, L., Liu, S., Tang, G., Zhou, C., & Chen, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311625 · Cited by 17 · see citing works
Tang, M., Cheng, S., Wang, L., Tang, H., Liu, T., Zhao, T., & Dang, R.-L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1165443 · Cited by 13 · see citing works
“In cohort studies, MetS and its components have been associated with more severe clinical depressive symptoms and a higher risk of MDD (Sagud et al., 2009; Hummel et al., 2011; Scharnholz et al., 2014).”
BackgroundSambamoorthi, U., Mitra, S., Findley, P. A., & POGACH, L. M. (2012) · Women s Health Issues · doi:10.1016/j.whi.2011.08.012 · Cited by 12 · see citing works
Liu, J., & Qi, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28558 · Cited by 11 · see citing works
Terevnikov, V., Stenberg, J., Tiihonen, J., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571200137x · Cited by 9 · see citing works
Yan, C., Wang, H., Liu, C., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1467142 · Cited by 8 · see citing works
Anxiety and dyslipidemia among primary health care professionals: A Cross-sectional study
Barbosa, C. D. S., das Merces, M. C., Santana, A. I. C., Silva, D. D. S. E., Pimentel, R. F. W., Coelho, J. M. F., Almeida, A. A. E., Damasceno, K. S. M., Rossi, T. R. A., & Júnior, A. D. (2022) · Work · doi:10.3233/wor-205095 · Cited by 11 · see citing works
Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review
Jia, F., Shi, S., Fei, S.-F., Zhou, M., & Li, J. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm24978 · Cited by 6 · see citing works
Uju, Y., Kanzaki, T., Yamasaki, Y., Kondo, T., Nanasawa, H., Takeuchi, Y., Yanagisawa, Y., Kusanishi, S., Nakano, C., Enomoto, T., et al. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00303-5 · Cited by 7 · see citing works
Unintended positive and negative effects of drugs on lipoproteins
Siahmansur, T. J., Schofield, J. D., Azmi, S., Liu, Y., Durrington, P. N., & Soran, H. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000198 · Cited by 5 · see citing works
“file improved after treatment with mirtazapine or venlafaxine [53].”
BackgroundSun, Z., Yang, J., Zhou, J., Zhou, J., Feng, L., Feng, Y., He, Y., Liu, M., Li, Y., Wang, G., et al. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2023.01.004 · Cited by 5 · see citing works
“Plasma cholesterol levels were assessed in the Clinical Laboratory of Beijing Anding Hospital using enzymatic methods (Modular; Roche Diagnostics) as described by Hummel et al. (46).”
MethodAffections métaboliques et psychiatrie
Duval, F. (2013) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(13)60022-x · Cited by 4 · see citing works
Pedraz‐Petrozzi, B., Lamadé, E. K., Schneiberg, R., Scharnholz, B., Vítků, J., Hill, M., Stárka, L., Gilles, M., & Deuschle, M. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106366 · Cited by 3 · see citing works
Self-citationMitra, S., Findley, P. A., Sambamoorthi, U., et al. (2011) · SSRN Electronic Journal · doi:10.2139/ssrn.1935976 · Cited by 2 · see citing works
Hormone Replacement Therapy (And Other Options to Treat Menopausal Symptoms)
Lambrinoudaki, I. V., Armeni, E., & Silionga, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-65952-2_12 · Cited by 1 · see citing works
Jing, A., Wang, J., Zhang, M., Liang, Y., Liu, J., Zhang, N., Wang, J., Li, X., Li, C., Cui, Z., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26495-y · Cited by 1 · see citing works
“Low levels of HDL-C have also been associated with depression 29 .”
Gitay, M. N., & Bano, S. (2013) · Journal of Basic & Applied Sciences · doi:10.6000/1927-5129.2013.09.35 · Cited by 1 · see citing works
“Hummel and coworkers concluded through a randomized open-label prospective trial that remission from depression with antidepressant treatment improves the LDL/HDL cholesterol ratio, shifting the lipoproteins towards a lesser atherogenic profile [27].”
BackgroundMetabolic Effects of Two Different Doses of Venlafaxine Therapy on Rats
Annamária, I., Kolcsár, M., Groșan, A., Imre, M., & Dogaru, M. T. (2015) · Acta Marisiensis. Seria Medica · doi:10.1515/amma-2015-0049 · Cited by 1 · see citing works
“Although other preclinical studies have not revealed any effect of venlafaxine on blood sugar level [9], our results present a significant decrease of blood glucose, despite of high triglyceride levels.”
ResultPositionspapier zur Bedeutung psychosozialer Faktoren in der Kardiologie
München, Z., Würzburg, U., Medizinische, I., Wuppertal-Herzzentrum, H.-K., & Ulm, U. (2013)
Depression, metabolisches Syndrom und kardiovaskuläre Erkrankungen
Deuschle, M., & Schweiger, U. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22484-3.00036-0
Self-citationTerevnikov, V., Stenberg, J., Tiihonen, J., et al. (2013) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Bhat, B. A., Dar, S., & Hussain, A. (2020) · Muller Journal of Medical Sciences and Research · doi:10.4103/mjmsr.mjmsr_26_19
Pedraz‐Petrozzi, B., Lamadé, E. K., Petry, R., Scharnholz, B., Vítků, J., Hill, M., Stárka, L., Gilles, M., & Deuschle, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2500567/v1
Self-citationYan, C., Zhou, Y., Wang, H., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4618010/v1
Relationship between apolipoprotein A1 and depression in Chinese adults
Wang, X., Wang, J., Zhao, J., et al. (2024) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2024.09.008
Treiber, M., Baune, B. T., Gramser, A., Saelens, J., Grüll, N., Rössler, K., Novak, K., Bouzouina, A., Thanarajah, S. E., Reif-Leonhard, C., et al. (2025) · medRxiv · doi:10.1101/2025.08.31.25334709
“Noteworthy, antidepressant treatment, such as electroconvulsive therapy and antidepressant medication have been reported to alter circulating cholesterol levels (Gabriel, 2007; Hummel et al., 2011).”
Genetic Polymorphisms and Gene-Environment Interactions in Persistent Post-Stroke Depression
Lan, Y., Li, X., Zhao, X., Liang, W., Pan, C., Qiu, X., Miao, J., Li, G., Zhu, Z., & Zhu, S. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s560475
“We attribute this non-significant finding to the relatively small sample size of the study, which may limit statistical power to detect subtle”
A novel sex-specific role for 27-hydroxycholesterol in early-onset schizophrenia
Sun, Z., Liu, M., Yan, J., Wu, Y., Wang, H., Li, Y., Tang, Y., Zheng, Y., & Li, R. (2026) · Annals of General Psychiatry · doi:10.1186/s12991-026-00642-9
“Levels of plasma cholesterol in EOS patients were measured by an enzymatic method (Modular; Roche Diag-nostics) as previously reported [29].”
Besondere Situationen bei Diabetes mellitus
Blüher, M., Druml, W., Ehren, M., Hummel, M., Kopf, D., Müssig, K., Pfohl, M., & Schifferdecker, E. (2014) · Springer eBooks · doi:10.1007/978-3-642-41358-2_9
Self-citation
- Authors
- Hummel, J., Westphal, S., Weber-Hamann, B., Gilles, M., Lederbogen, F., Angermeier, T., Luley, C., Deuschle, M., & Kopf, D.
- Affiliations
- Central Institute of Mental Health (DE)
- Corresponding author
- Kopf, Daniel
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2011-01-25
- Volume
- 72
- Issue
- 07
- Pages
- 885-891
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2042208628
- Cited by
- 60
- References
- 0
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 9 · 2014: 3 · 2013: 8 · 2012: 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- major depressive disorder, serum lipoproteins, cardiovascular risk, antidepressant response, mirtazapine, venlafaxine, LDL cholesterol, HDL cholesterol, LDL/HDL ratio, apolipoprotein A-I, apolipoprotein B, remission, treatment non-response, hypertriglyceridemia
- MeSH terms
- Venlafaxine Hydrochloride, Mirtazapine, Adult, Antidepressive Agents, Apolipoproteins B, Cholesterol, Cross-Sectional Studies, Cyclohexanols, Major Depressive Disorder, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Mianserin, Middle Aged, Personality Inventory, Prospective Studies, Triglycerides, Apolipoprotein A-I, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
